Rotavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Rotavirus is a virus that infects infants and children. Its symptoms may include severe diarrhea, vomiting, fever, and dehydration.
The Rotavirus Infections pipeline drugs market research report provides an analysis of the Rotavirus Infections drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects.
Rotavirus Infections Pipeline Drugs Market Segmentation by Target
The target of the Rotavirus Infections pipeline drugs market is VP6 Antigen.
Rotavirus Infections Pipeline Drugs Market Segmentation by Mechanism of Action
The mechanism of action of Rotavirus Infections pipeline drugs market is VP6 Antigen Inhibitor.
Rotavirus Infections Pipeline Drugs Market Segmentation by Routes of Administration
The routes of administration in the Rotavirus Infections pipeline drugs market are oral, intramuscular, parenteral, subcutaneous, and transdermal.
Rotavirus Infections Pipeline Drugs Market Analysis, by Routes of Administration
To know more about the RoA in the Rotavirus Infections pipeline drugs market, download a free report sample
Rotavirus Infections Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the Rotavirus Infections pipeline drugs market are Live Attenuated Vaccine, Subunit Vaccine, Inactivated Vaccine, Monoclonal Antibody, Conjugate Vaccine, DNA Vaccine, mRNA Vaccine, Recombinant Vector Vaccine, and Vaccine.
Rotavirus Infections Pipeline Drugs Market Analysis, by Molecule Types
To know more about the molecule types in the Rotavirus Infections pipeline drugs market, download a free report sample
Competitive Landscape
Some of the leading companies in the Rotavirus Infections pipeline drugs market are Aridis Pharmaceuticals Inc, Beijing Minhai Biotechnology Co Ltd, Bharat Biotech Ltd, Blue Water Vaccines Inc, Chain Biotechnology Ltd, Chongqing Zhifei Biological Products Co Ltd, ConserV Bioscience Ltd, Curevac NV, and GSK plc among others.
Rotavirus Infections Pipeline Drugs Market Analysis, by Leading Companies
To know more about the leading companies in the Rotavirus Infections pipeline drugs market , download a free report sample
Rotavirus Infections Pipeline Drugs Market Report Overview
| Key Target | VP6 Antigen |
| Key Mechanism of Action | VP6 Antigen Inhibitor |
| Key Routes of Administration | Oral, Intramuscular, Parenteral, Subcutaneous, and Transdermal |
| Key Molecule Types | Live Attenuated Vaccine, Subunit Vaccine, Inactivated Vaccine, Monoclonal Antibody, Conjugate Vaccine, DNA Vaccine, mRNA Vaccine, Recombinant Vector Vaccine, and Vaccine |
| Key Companies | Aridis Pharmaceuticals Inc, Beijing Minhai Biotechnology Co Ltd, Bharat Biotech Ltd, Blue Water Vaccines Inc, Chain Biotechnology Ltd, Chongqing Zhifei Biological Products Co Ltd, ConserV Bioscience Ltd, Curevac NV, and GSK plc |
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Rotavirus Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Rotavirus Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Rotavirus Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Rotavirus Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Rotavirus Infections (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Rotavirus Infections (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Rotavirus Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech Ltd
Blue Water Vaccines Inc
Chain Biotechnology Ltd
Chongqing Zhifei Biological Products Co Ltd
ConserV Bioscience Ltd
Curevac NV
GSK plc
Hilleman Laboratories Pvt Ltd
IGY Immune Technologies & Life Sciences Inc
Inventprise LLC
Medicago Inc
Micron Biomedical Inc
Serum Institute of India Pvt Ltd
SK Bioscience Ltd
Symvivo Inc
Wuhan Institute of Biological Products Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Rotavirus Infections pipeline drugs market?
The target of the Rotavirus Infections pipeline drugs market is VP6 Antigen.
-
What are the mechanisms of action of the Rotavirus Infections pipeline drugs market?
The key mechanism of action of the Rotavirus Infections pipeline drugs market is the VP6 Antigen Inhibitor.
-
What are the top routes of administration in the Rotavirus Infections pipeline drugs market?
The routes of administration in the Rotavirus Infections pipeline drugs market are oral, intramuscular, parenteral, subcutaneous, and transdermal.
-
What are the molecule types in the Rotavirus Infections pipeline drugs market?
The molecule types in the Rotavirus Infections pipeline drugs market are Live Attenuated Vaccine, Subunit Vaccine, Inactivated Vaccine, Monoclonal Antibody, Conjugate Vaccine, DNA Vaccine, mRNA Vaccine, Recombinant Vector Vaccine, and Vaccine.
-
Which are the leading companies in the Rotavirus Infections pipeline drugs market?
Some of the leading companies in the Rotavirus Infections pipeline drugs market are Aridis Pharmaceuticals Inc, Beijing Minhai Biotechnology Co Ltd, Bharat Biotech Ltd, Blue Water Vaccines Inc, Chain Biotechnology Ltd, Chongqing Zhifei Biological Products Co Ltd, ConserV Bioscience Ltd, Curevac NV, and GSK plc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Rotavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Infectious Disease reports